KATHMANDU, Oct 17: The government has issued permits to import, sales and distribution of Remdesivir, an anti-viral drug used in treating COVID-19, in Nepal.
The Department of Drug Administration has issued permits to three companies-two Nepali and one Indian- for the same, informed Dr Samir Kumar Adhikari, deputy spokesperson at the Ministry of Health and Population.
Yeti Pharmacy Distributors Pvt. Ltd, Lalitpur and Synergy Overseas Pvt. Ltd, Kathmandu are the Nepali companies and Hetero Labs Limited is the Indian company.